These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19164238)

  • 21. Myocardial contractile reserve determined by dobutamine stress Tc-99m tetrofosmin quantitative gated SPECT predicts late spontaneous improvement in cardiac function in patients with recent-onset dilated cardiomyopathy.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Cardiol; 2003; 10(6):607-14. PubMed ID: 14668772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.
    de Groote P; Delour P; Mouquet F; Lamblin N; Dagorn J; Hennebert O; Le Tourneau T; Foucher-Hossein C; Verkindère C; Bauters C
    Am Heart J; 2007 Sep; 154(3):589-95. PubMed ID: 17719311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
    Kurum T; Tatli E; Yuksel M
    Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure.
    O'Keefe JH; Magalski A; Stevens TL; Bresnahan DR; Alaswad K; Krueger SK; Bateman TM
    J Nucl Cardiol; 2000; 7(1):3-7. PubMed ID: 10698228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.
    Neglia D; De Maria R; Masi S; Gallopin M; Pisani P; Pardini S; Gavazzi A; L'abbate A; Parodi O
    Heart; 2007 Jul; 93(7):808-13. PubMed ID: 17237134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
    Maunoury C; Acar P; Sidi D
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1651-6. PubMed ID: 14504829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dobutamine gated blood pool scintigraphy predicts the improvement of cardiac sympathetic nerve activity, cardiac function, and symptoms after treatment in patients with dilated cardiomyopathy.
    Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Suzuki T; Kurabayashi M
    Chest; 2002 Aug; 122(2):542-8. PubMed ID: 12171829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.
    Watanabe K; Takahashi T; Nakazawa M; Wahed MI; Fuse K; Tanabe N; Kodama M; Aizawa Y; Ashino H; Tazawa S
    J Nucl Med; 2002 Apr; 43(4):531-5. PubMed ID: 11937598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
    Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
    Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS
    Echocardiography; 2005 Aug; 22(7):547-54. PubMed ID: 16060890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonic tissue characterization can predict beta-blocker efficacy in dilated cardiomyopathy.
    Kondo I; Mizushige K; Nozaki S; Iwado Y; Hirao K; Senda S; Kohno M; Matsuo H
    Ultrasound Med Biol; 2001 Aug; 27(8):1079-86. PubMed ID: 11527594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy.
    Merlet P; Delforge J; Syrota A; Angevin E; Mazière B; Crouzel C; Valette H; Loisance D; Castaigne A; Randé JL
    Circulation; 1993 Apr; 87(4):1169-78. PubMed ID: 8096441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
    Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
    J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
    Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
    J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388.
    de Jong RM; Willemsen AT; Slart RH; Blanksma PK; van Waarde A; Cornel JH; Vaalburg W; van Veldhuisen DJ; Elsinga PH
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):443-7. PubMed ID: 15592928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
    Böhm M; Ettelbrück S; Flesch M; van Gilst WH; Knorr A; Maack C; Pinto YM; Paul M; Teisman AC; Zolk O
    Cardiovasc Res; 1998 Oct; 40(1):146-55. PubMed ID: 9876327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of dilated cardiomyopathy with carvedilol in children.
    Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
    Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
    Ramahi TM; Longo MD; Cadariu AR; Rohlfs K; Slade M; Carolan S; Vallejo E; Wackers FJ
    Eur Heart J; 2001 May; 22(10):849-56. PubMed ID: 11350094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.